Trastuzumab
Correlation of Her-2 neu over-expression with clinico pathological features of carcinoma breast
HER-2/neu:Predictive Marker for Response to Breast Cancer Therapy Mark Pegram, M.D. Associate Professor of Medicine Director, Women’s Cancer Program UCLA/Jonsson.
